UniProtKB/Swiss-Prot Q08257: Variant p.Glu183Lys

Quinone oxidoreductase
Gene: CRYZ
Feedback?

Variant information Variant position:

183 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamate (E) to Lysine (K) at position 183 (E183K, p.Glu183Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs17095822 [ dbSNP | Ensembl ]

Sequence information Variant position:

183 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

329 The length of the canonical sequence.
Location on the sequence:

LAACQIARAYGLKILGTAGT E EGQKIVLQNGAHEVFNHREV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LAACQIARAYGLKILGTAGTEEGQKIVLQNGAHEVFNHREV

Mouse                         LATCQIARAHGLKVLGTAGSEEGKKLVLQNGAHEVFNHKEA

Rat                           LATCQIARAHGLKVLGTAGSEEGKKLVLQNGAHEVFNHKEA

Pig                           IAACQIARAYGLKVLGTAGTEEGQNIVLQNGAHEVFNHREV

Bovine                        IAACQIARAYGLKVLGTASTEEGQKIVLENGAHKVFNHKEA

Baker's yeast                 LILNQLLKMKGAHTIAVASTDEKLKIAKEYGAEYLINASKE

Fission yeast                 LLLCQMLRARNVHVIATASTAAKRRIAIKNGAEIACSYEDL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 329	Quinone oxidoreductase
Binding site	181 – 181
Binding site	200 – 200
Helix	183 – 191

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.